{"name":"Emercell SAS","slug":"emercell-sas","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPNVpwSTdRNUY3MzR3TXcya19CMld4Sk9oVVdVVnlYaXM1ZzhsTzFWUFAyT2ZlSEN1b21LWDNmV1J2c19zSkg2STlDVmw2THc3NHo2TmR6NmJsZ0p4ckJYY05LdDVDM0hON3JkdER1Wm5IZUJmOVBJWWtkQ1pVTDZnZTh5NmI1cFNNdHFvN3pqZnUtWmh4UzhTSWZsTFpTSjUyOTBHQWhiSWs1TmpaMHcyZTd4WTdJaVg4bktLbXR1cTk2MzBxZ3hmcWQwNDIzZklTLWpyYXl1RE16QVZHZDZETXhJYlhwUQ?oc=5","date":"2022-09-22","type":"pipeline","source":"businesswire.com","summary":"Emercell and Cell-Easy Sign a Strategic Agreement for the Scale-up and Manufacturing of NK-001 - businesswire.com","headline":"Emercell and Cell-Easy Sign a Strategic Agreement for the Scale-up and Manufacturing of NK-001","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNMnFiQ1RCZjdUUXdGMW1saVBLVVZDWnNURUFueXl4OUcwNDV2eUNGb2tsQ2dKaUItT29zWjF3Z2h4RzM2OUFmQkRBRXJOVk4td3BvTWVaa3Jjak03RkUyVDJmM1JUam5VN3pUeUhXT0YwcVNVZVNvUnFvNnIzVkFhQXVwRlNOTXo2SzRZOWZOMTdhX1A5LVZoaHI3NFZVZkhnVG5Vc3NmRjhfMFgzcWhod3UtdEN4OEdyd193ei1hYXVjTXA0ZDliUXJQbjEtMkVFVlRBSm1xc0JVbFZRcDdDTnFQaHhYSUptUW9aTHVBdGlJSXNpV1E?oc=5","date":"2021-02-17","type":"pipeline","source":"PR Newswire","summary":"Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy - PR Newswire","headline":"Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}